INSIDER · CIK 2034665
Cohlhepp Ryan
President, COO & Interim CEO, Director at Bicara Therapeutics Inc. (BCAX)
↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$925KSold on the market
1Companies
Sep 10, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 202616:23 | Sep 8, 2026 | BCAXBicara Therapeutics Inc. | President, COO & Interim CEO, Director | S · Sell10b5-1 | $22.90 | −17,500 | 181,641 | -9% | −$401K | ||
| Sep 10, 202616:23 | Sep 8, 2026 | BCAXBicara Therapeutics Inc. | President, COO & Interim CEO, Director | M · Exercise10b5-1 | $3.79 | +17,500 | 199,141 | +10% | $66K | ||
| Aug 12, 202616:19 | Aug 10, 2026 | BCAXBicara Therapeutics Inc. | President and COO, Director | S · Sell10b5-1 | $27.98 | −18,750 | 181,641 | -9% | −$525K | ||
| Aug 12, 202616:19 | Aug 10, 2026 | BCAXBicara Therapeutics Inc. | President and COO, Director | M · Exercise10b5-1 | $3.79 | +18,750 | 200,391 | +10% | $71K |